Brain Emergency Management Initiative for Optimizing Hub-Helicopter Emergency Medical Systems-Spoke Transfer Networks

Air Med J. 2020 Mar-Apr;39(2):103-106. doi: 10.1016/j.amj.2019.10.003. Epub 2019 Nov 1.

Abstract

Objective: Embolectomy is standard for select occlusions up to 24 hours. Transfer patients may have worse outcomes than those originating in embolectomy centers. We developed the Brain Emergency Management Initiative (BEMI) protocol to streamline this transfer process and mimic the urgency that surrounds ST-elevation myocardial infarction cardiac evaluations.

Methods: We conducted an exploratory assessment of consecutive acute telestroke patients transferred for potential intervention in pre-BEMI versus BEMI periods. Times included spoke in, spoke out, hub in, and groin puncture. Outcomes included discharge destination and symptomatic intracranial hemorrhage.

Results: Overall, 68 transfers were assessed. There was a higher National Institute of Neurological Disorders and Stroke in BEMI (11 pre-BEMI vs. 20 B.M., P = .01). There were shorter spoke door in to door out (143 vs. 118 minutes, P = .01) and spoke door out to hub door in times (23 minutes pre-BEMI vs. 21 minutes BEMI, P = .001). For embolectomy patients, there was shorter hub door in to reperfusion (83 minutes pre-BEMI vs. 74 minutes BEMI, P = .04) and recombinant tissue plasminogen decision to groin puncture (155 minutes pre-BEMI vs. 130 minutes BEMI; P = .01). There were no symptomatic intracranial hemorrhage or discharge differences.

Conclusion: In our hub-helicopter emergency medical services-spoke telestroke network, BEMI led to improved evaluation times. BEMI may serve as a model for future rapid stroke transfer pathways.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Air Ambulances*
  • Embolectomy*
  • Emergency Medical Services / methods*
  • Emergency Medical Services / organization & administration
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Patient Transfer / methods*
  • Patient Transfer / organization & administration
  • Remote Consultation
  • Retrospective Studies
  • Stroke / therapy*
  • Thrombolytic Therapy*
  • Time Factors
  • Time-to-Treatment / statistics & numerical data*
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator